Your browser doesn't support javascript.
loading
A comparative cost-utility analysis of postoperative calcium supplementation strategies used in the current management of hypocalcemia.
Nicholson, Kristina J; Smith, Kenneth J; McCoy, Kelly L; Carty, Sally E; Yip, Linwah.
Afiliação
  • Nicholson KJ; Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh, PA.
  • Smith KJ; Department of Medicine, University of Pittsburgh, PA.
  • McCoy KL; Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh, PA.
  • Carty SE; Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh, PA.
  • Yip L; Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh, PA. Electronic address: yipl@upmc.edu.
Surgery ; 167(1): 137-143, 2020 01.
Article em En | MEDLINE | ID: mdl-31515122
BACKGROUND: Symptomatic hypocalcemia is a common complication of total thyroidectomy. Management strategies include responsive treatment initiation for symptoms or prevention by routine or parathyroid hormone-directed calcium supplementation. The comparative cost-effectiveness of even the most often utilized strategies is unclear. METHODS: A Markov cohort model was created to compare routine supplementation with calcium alone (RS), postoperative parathyroid hormone-based selective supplementation with calcium and calcitriol (SS), and no supplementation (NS) in asymptomatic patients. Patients could remain asymptomatic or develop symptomatic hypocalcemia, managed with outpatient oral supplementation or intravenous calcium infusion and administered either inpatient or outpatient. Effectiveness was measured in quality-adjusted life years. Sensitivity analyses were performed to test model parameter assumptions. RESULTS: RS was the preferred strategy, costing $329/patient and resulting in 0.497 quality-adjusted life years, which was only marginally better compared to SS ($373 for 0.495 quality-adjusted life years). NS was most costly at $4,955 for 0.491 quality-adjusted life years. Preference for RS over SS was sensitive to the probability of developing symptoms and the probability of symptom treatment with intravenous supplementation. On probabilistic sensitivity analysis, RS was preferred in 75.4% of scenarios. CONCLUSION: After total thyroidectomy, a preventative calcium supplementation strategy should be strongly considered. In this data-driven theoretical model, RS was the least costly option and resulted in an incremental gain in quality-adjusted life years.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Tireoidectomia / Análise Custo-Benefício / Suplementos Nutricionais / Hipocalcemia Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Surgery Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Tireoidectomia / Análise Custo-Benefício / Suplementos Nutricionais / Hipocalcemia Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Surgery Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos